These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 28067072)
1. Drug target identification at the crossroad of neuronal apoptosis and survival. Maino B; Paparone S; Severini C; Ciotti MT; D'agata V; Calissano P; Cavallaro S Expert Opin Drug Discov; 2017 Mar; 12(3):249-259. PubMed ID: 28067072 [TBL] [Abstract][Full Text] [Related]
2. Systems biology of apoptosis and survival: implications for drug development. Pezzino S; Paratore S; Cavallaro S Curr Pharm Des; 2011; 17(3):190-203. PubMed ID: 21348833 [TBL] [Abstract][Full Text] [Related]
3. Targeting erythropoietin for chronic neurodegenerative diseases. Chong ZZ; Shang YC; Mu Y; Cui S; Yao Q; Maiese K Expert Opin Ther Targets; 2013 Jun; 17(6):707-20. PubMed ID: 23510463 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional landscapes at the intersection of neuronal apoptosis and substance P-induced survival: exploring pathways and drug targets. Paparone S; Severini C; Ciotti MT; D'Agata V; Calissano P; Cavallaro S Cell Death Discov; 2016; 2():16050. PubMed ID: 27551538 [TBL] [Abstract][Full Text] [Related]
5. Modulation of neurotrophic signaling pathways by polyphenols. Moosavi F; Hosseini R; Saso L; Firuzi O Drug Des Devel Ther; 2016; 10():23-42. PubMed ID: 26730179 [TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic drugs: a therapautic strategy for the prevention of neurodegenerative diseases. Sureda FX; Junyent F; Verdaguer E; Auladell C; Pelegri C; Vilaplana J; Folch J; Canudas AM; Zarate CB; Pallès M; Camins A Curr Pharm Des; 2011; 17(3):230-45. PubMed ID: 21348832 [TBL] [Abstract][Full Text] [Related]
7. Drug target identification for neuronal apoptosis through a genome scale screening. Tendi EA; Cunsolo R; Bellia D; Messina RL; Paratore S; Calissano P; Cavallaro S Curr Med Chem; 2010; 17(26):2906-20. PubMed ID: 20858172 [TBL] [Abstract][Full Text] [Related]
8. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases. Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468 [TBL] [Abstract][Full Text] [Related]
9. Treating neurodegenerative conditions through the understanding of neuronal apoptosis. D'Mello SR; Chin PC Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):3-23. PubMed ID: 15723610 [TBL] [Abstract][Full Text] [Related]
15. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases. Serafino A; Sferrazza G; Colini Baldeschi A; Nicotera G; Andreola F; Pittaluga E; Pierimarchi P Expert Opin Drug Discov; 2017 Feb; 12(2):169-186. PubMed ID: 27960558 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits. Benetti F; Gustincich S; Legname G Expert Opin Drug Discov; 2012 Mar; 7(3):245-59. PubMed ID: 22468955 [TBL] [Abstract][Full Text] [Related]
17. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery. Corti S; Faravelli I; Cardano M; Conti L Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional Profiles of Cell Fate Transitions Reveal Early Drivers of Neuronal Apoptosis and Survival. Morello G; Villari A; Spampinato AG; La Cognata V; Guarnaccia M; Gentile G; Ciotti MT; Calissano P; D'Agata V; Severini C; Cavallaro S Cells; 2021 Nov; 10(11):. PubMed ID: 34831459 [TBL] [Abstract][Full Text] [Related]
19. Interrupting apoptosis in neurodegenerative disease: potential for effective therapy? Waldmeier PC; Tatton WG Drug Discov Today; 2004 Mar; 9(5):210-8. PubMed ID: 14980539 [TBL] [Abstract][Full Text] [Related]